Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher F Van der Walle

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of Pharmaceutical Sciences|August 28, 2007
Engineering biodegradable polyester particles with specific drug targeting and drug release propertiesFarahidah Mohamed, Christopher F van der Walle
Protein and Peptide Letters|January 29, 2008
The heavy-light chain loop of human cathepsin-L modulates its activity and stabilityMichael Fairhead, Christopher F van der Walle
International Journal of Pharmaceutics|January 18, 2006
PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNAFarahidah Mohamed, Christopher F van der Walle
Journal of Cellular Physiology|May 1, 2010
Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiologyJames Beattie, Lisa McIntosh, Christopher F van der Walle
FEBS Letters|December 17, 2003
The intestinal zonula occludens toxin (ZOT) receptor recognises non-native ZOT conformers and localises to the intercellular contactsAlvin Lee, Natalie White, Christopher F van der Walle
Protein Engineering|February 26, 2003
Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activityChristopher F van der Walle, Harri Altroff, Helen J Mardon
Biochemical and Biophysical Research Communications|December 19, 2007
A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activationMichael Fairhead, Sharon M Kelly, Christopher F van der Walle
Expert Opinion on Drug Delivery|February 26, 2009
Current approaches to stabilising and analysing proteins during microencapsulation in PLGAChristopher F van der Walle, Gaurav Sharma, Mnv Ravi Kumar
International Journal of Pharmaceutics|January 10, 2012
Therapeutic antibodies: market considerations, disease targets and bioprocessingJohn G Elvin, Ruairidh G Couston, Christopher F van der Walle
Pharmaceutics|August 28, 2021
Formulation Considerations for Autologous T Cell Drug ProductsChristopher F van der Walle, Sonya Godbert, Gabriele Saito, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of Pharmaceutical Sciences|August 28, 2007
Engineering biodegradable polyester particles with specific drug targeting and drug release propertiesFarahidah Mohamed, Christopher F van der Walle
Protein and Peptide Letters|January 29, 2008
The heavy-light chain loop of human cathepsin-L modulates its activity and stabilityMichael Fairhead, Christopher F van der Walle
International Journal of Pharmaceutics|January 18, 2006
PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNAFarahidah Mohamed, Christopher F van der Walle
Journal of Cellular Physiology|May 1, 2010
Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiologyJames Beattie, Lisa McIntosh, Christopher F van der Walle
FEBS Letters|December 17, 2003
The intestinal zonula occludens toxin (ZOT) receptor recognises non-native ZOT conformers and localises to the intercellular contactsAlvin Lee, Natalie White, Christopher F van der Walle
Protein Engineering|February 26, 2003
Novel mutant human fibronectin FIII9-10 domain pair with increased conformational stability and biological activityChristopher F van der Walle, Harri Altroff, Helen J Mardon
Biochemical and Biophysical Research Communications|December 19, 2007
A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activationMichael Fairhead, Sharon M Kelly, Christopher F van der Walle
Expert Opinion on Drug Delivery|February 26, 2009
Current approaches to stabilising and analysing proteins during microencapsulation in PLGAChristopher F van der Walle, Gaurav Sharma, Mnv Ravi Kumar
International Journal of Pharmaceutics|January 10, 2012
Therapeutic antibodies: market considerations, disease targets and bioprocessingJohn G Elvin, Ruairidh G Couston, Christopher F van der Walle
Pharmaceutics|August 28, 2021
Formulation Considerations for Autologous T Cell Drug ProductsChristopher F van der Walle, Sonya Godbert, Gabriele Saito, et al.
Pageof 7